88 related articles for article (PubMed ID: 2820419)
1. Monoclonal antibody C3.1 is a platelet derived growth factor (PDGF) antagonist.
Kawahara RS; Kennedy BB; Deuel TF
Biochem Biophys Res Commun; 1987 Sep; 147(2):839-45. PubMed ID: 2820419
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the platelet-derived growth factor-stimulated tyrosine phosphorylation of the platelet-derived growth factor receptor in vivo. Immunopurification using a monoclonal antibody to phosphotyrosine.
Frackelton AR; Tremble PM; Williams LT
J Biol Chem; 1984 Jun; 259(12):7909-15. PubMed ID: 6203898
[TBL] [Abstract][Full Text] [Related]
3. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
Huang JS; Nishimura J; Huang SS; Deuel TF
J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
[TBL] [Abstract][Full Text] [Related]
4. Ligand activation causes a phosphorylation-dependent change in platelet-derived growth factor receptor conformation.
Keating MT; Escobedo JA; Fantl WJ; Williams LT
Trans Assoc Am Physicians; 1988; 101():24-32. PubMed ID: 2480016
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody against PDGF B-chain inhibits PDGF-induced DNA synthesis in C3H fibroblasts and prevents binding of PDGF to its receptor.
Vassbotn FS; Langeland N; Hagen I; Holmsen H
Biochim Biophys Acta; 1990 Sep; 1054(2):246-9. PubMed ID: 2169313
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of the high affinity epidermal growth factor receptor on cell-free membranes after transmodulation by platelet-derived growth factor.
Walker F; Burgess AW
J Biol Chem; 1991 Feb; 266(5):2746-52. PubMed ID: 1993654
[TBL] [Abstract][Full Text] [Related]
7. Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation.
Bremer EG; Hakomori S; Bowen-Pope DF; Raines E; Ross R
J Biol Chem; 1984 Jun; 259(11):6818-25. PubMed ID: 6327695
[TBL] [Abstract][Full Text] [Related]
8. Purification of the platelet-derived growth factor receptor by using an anti-phosphotyrosine antibody.
Daniel TO; Tremble PM; Frackelton AR; Williams LT
Proc Natl Acad Sci U S A; 1985 May; 82(9):2684-7. PubMed ID: 2581254
[TBL] [Abstract][Full Text] [Related]
9. Characterization of two monoclonal antibodies reactive with the external domain of the platelet-derived growth factor receptor.
Rönnstrand L; Terracio L; Claesson-Welsh L; Heldin CH; Rubin K
J Biol Chem; 1988 Jul; 263(21):10429-35. PubMed ID: 2455716
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, phosphorylation, and degradation of multiple forms of the platelet-derived growth factor receptor studied using a monoclonal antibody.
Hart CE; Seifert RA; Ross R; Bowen-Pope DF
J Biol Chem; 1987 Aug; 262(22):10780-5. PubMed ID: 2440874
[TBL] [Abstract][Full Text] [Related]
11. PDGF induces c-myc mRNA expression in MG-63 human osteosarcoma cells but does not stimulate cell replication.
Womer RB; Frick K; Mitchell CD; Ross AH; Bishayee S; Scher CD
J Cell Physiol; 1987 Jul; 132(1):65-72. PubMed ID: 2439522
[TBL] [Abstract][Full Text] [Related]
12. PDGF stimulates transient phosphorylation of 180,000 dalton protein.
Harrington MA; Estes JE; Leof E; Pledger WJ
J Cell Biochem; 1985; 27(2):67-81. PubMed ID: 2985636
[TBL] [Abstract][Full Text] [Related]
13. Gangliosides inhibit platelet-derived growth factor-stimulated receptor dimerization in human glioma U-1242MG and Swiss 3T3 cells.
Van Brocklyn J; Bremer EG; Yates AJ
J Neurochem; 1993 Jul; 61(1):371-4. PubMed ID: 8515285
[TBL] [Abstract][Full Text] [Related]
14. Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: their action in smooth muscle cells in vitro.
Rossi MJ; Chegini N; Masterson BJ
Endocrinology; 1992 Mar; 130(3):1716-27. PubMed ID: 1311246
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms through which gangliosides inhibit PDGF-stimulated mitogenesis in intact Swiss 3T3 cells: receptor tyrosine phosphorylation, intracellular calcium, and receptor binding.
Yates AJ; VanBrocklyn J; Saqr HE; Guan Z; Stokes BT; O'Dorisio MS
Exp Cell Res; 1993 Jan; 204(1):38-45. PubMed ID: 8416794
[TBL] [Abstract][Full Text] [Related]
16. Effect of the different dimeric forms of the platelet-derived growth factor on cellular responses in mouse Swiss 3T3 fibroblasts.
Sturani E; Brambilla R; Morello L; Cattaneo MG; Zippel R; Alberghina L
FEBS Lett; 1989 Sep; 255(1):191-5. PubMed ID: 2551728
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of platelet-derived growth factor autocrine growth stimulation by a monoclonal antibody to the human alpha platelet-derived growth factor receptor.
LaRochelle WJ; Jensen RA; Heidaran MA; May-Siroff M; Wang LM; Aaronson SA; Pierce JH
Cell Growth Differ; 1993 Jul; 4(7):547-53. PubMed ID: 7691151
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of platelet-derived growth factor-mediated signal transduction by transforming ras. Suppression of receptor autophosphorylation.
Rake JB; Quiñones MA; Faller DV
J Biol Chem; 1991 Mar; 266(8):5348-52. PubMed ID: 1848245
[TBL] [Abstract][Full Text] [Related]
20. A novel monoclonal antibody dependent on domain 5 of the platelet-derived growth factor beta receptor inhibits ligand binding and receptor activation.
Ramakrishnan V; Escobedo MA; Fretto LJ; Seroogy JJ; Tomlinson JE; Wolf DL
Growth Factors; 1993; 8(4):253-65. PubMed ID: 8347343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
